Free Trial

Genus (LON:GNS) Hits New 1-Year High - Time to Buy?

Genus logo with Medical background

Key Points

  • Genus plc shares reached a new 52-week high of GBX 2,550 ($33.81) during trading, indicating a significant upward trend in stock performance.
  • Analysts from both Shore Capital and Deutsche Bank have rated Genus as a "buy," with target prices of GBX 2,750 ($36.46) and GBX 2,550 ($33.81) respectively.
  • Genus operates in the animal genetics sector, boasting a market cap of £1.64 billion, and showed a trading increase of 0.7%.
  • Looking to Export and Analyze Genus Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Genus plc (LON:GNS - Get Free Report)'s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 2,550 ($33.86) and last traded at GBX 2,479.99 ($32.93), with a volume of 32029 shares trading hands. The stock had previously closed at GBX 2,510 ($33.33).

Analyst Ratings Changes

Several equities research analysts have issued reports on GNS shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Genus from GBX 2,250 ($29.88) to GBX 2,550 ($33.86) and gave the company a "buy" rating in a research report on Tuesday, July 15th. Shore Capital reissued a "buy" rating and issued a GBX 2,750 ($36.52) target price on shares of Genus in a report on Tuesday, July 15th.

Read Our Latest Research Report on Genus

Genus Stock Performance

The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The business has a 50 day simple moving average of GBX 2,146.49 and a two-hundred day simple moving average of GBX 1,950.48. The firm has a market cap of £1.65 billion, a PE ratio of 209.30, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines